The elderly still stand to benefit from lipid-lowering therapy
High LDL cholesterol (LDL-C) levels are associated with the greatest absolute risk of myocardial infarction (MI) and atherosclerotic cardiovascular disease (ASCVD) in elderly people aged 70–100 years than other age groups in a contemporary primary prevention cohort — indicating that LDL-C is an important risk factor for CVD in the elderly, in contrast to historical studies.
